Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 Food and Drug Administration.

Clinic 104

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 104

AuntMinnie

NOVEMBER 21, 2024

All studies in the sole slated session on novel radiopharmaceuticals this year are on FAPI-PET tracers. For more information on those presentations and other abstracts, see the full RSNA 2024 meeting program. They appear promising for detecting liver cancer, bladder cancer, breast cancer, and interstitial lung disease. 9:10 a.m. |

Nuclear Medicine 105

Nuclear Medicine Imaging Radiopharmaceuticals Disease 105

Imaging Technology

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:57 June 7, 2024 — Shine Technologies, LLC , a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics , a Bracco company and recognized leader in the development of innovative radiopharmaceuticals. Statistically, approximately 12.9%

IT 105

IT Radiopharmaceuticals Clinic Diagnose 105

Imaging Technology

JANUARY 12, 2024

milla1cf Fri, 01/12/2024 - 11:09 January 12, 2024 — RefleXion Medical , Inc., We are grateful that CMS recognizes the potential of our SCINTIX therapy for patients with all stages of indicated cancers and, with this decision, has addressed provider payment as a barrier to clinical adoption,” continued Powell.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Medicare Clinic 105

Imaging Technology

JULY 9, 2024

I congratulate Marco Campione on this CEO appointment and we look forward to drawing upon his strategic, operational and broad general business expertise as we increase our global leadership throughout the diagnostic radiopharmaceutical industry,” said Fulvio Renoldi Bracco, CEO of Bracco Imaging. Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

Imaging Technology

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:50 July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd. , This agreement could be instrumental to the radiopharmaceutical industry and patient health. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Imaging Technology

FEBRUARY 14, 2024

milla1cf Wed, 02/14/2024 - 18:28 February 14, 2024 — PanTera , the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, today announces the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in the second half of 2024.

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Medical Clinic 105

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

AuntMinnie

JULY 12, 2024

Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Underwood led the nuclear medicine and radiopharmaceutical therapy team within radiation safety at Mayo Clinic and directly supports the program in Rochester.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

JANUARY 23, 2024

We see a growing interest for these high energy machines, driven by an increasing number of clinical trials exploring new diagnostic or radiotherapeutic molecules.” For more information: www.iba-worldwide.com Tuesday, January 23, 2024 - 13:47 If you enjoy this content, please share it with a colleague

Radiopharmaceuticals 111

Radiopharmaceuticals Disease Diagnostic Clinic 111

Imaging Technology

JUNE 11, 2024

SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Patient Care Medical 52

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. This alliance will help UH expand patient access and transform cancer care from discovery to recovery.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

Imaging Technology

JULY 5, 2024

mtaschetta-millane Fri, 07/05/2024 - 06:00 July 5, 2024 — Lantheus Holdings, Inc. , mtaschetta-millane Fri, 07/05/2024 - 06:00 July 5, 2024 — Lantheus Holdings, Inc. , For more information: www.lantheus.com Friday, July 5, 2024 - 06:00

Diagnostic 105

Diagnostic Radiopharmaceuticals Disease IT 105

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 92

Medical Radiopharmaceuticals Pharmaceutical Radiation 92

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

AUGUST 28, 2023

The companies will work together to increase near-term production of 225Ac [1] to support ongoing clinical trials and to ensure the large-scale supply of the radioisotope in the long term, addressing growing global demand. Whilst there is high demand, there is a scarcity of 225Ac.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

NOVEMBER 1, 2024

In other radiology oriented provisions, the final rule also addresses payment for radiopharmaceuticals in physician offices. next year compared with average payment rates for most of 2024. Also, the finalized average payment rates under the MPFS will be reduced by 2.9%

Radiopharmaceuticals 85

Radiopharmaceuticals Medicare Computed Tomography Hospital 85

Imaging Technology

APRIL 2, 2024

milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Journal of European Urology.

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

FEBRUARY 15, 2024

mtaschetta-millane Thu, 02/15/2024 - 12:50 February 15, 2024 — According to a release issued by the U.S. Scenario 2: Detector above the center of the gantry: If the support component fails, the detector will remain in place, and will not move as intended for clinical imaging, resulting in an interruption to normal system operation.

Computed Tomography 95

Computed Tomography Imaging Medical Device Radiopharmaceuticals 95

Imaging Technology

OCTOBER 21, 2024

tim.hodson Mon, 10/21/2024 - 10:17 Oct. 21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in its syngo.PET Cortical Analysis software application that use positron emission tomography (PET) to measure protein deposits in the brain associated with Alzheimer’s disease.

Disease 52

Disease Radiopharmaceuticals PET Scan Clinic 52

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

OCTOBER 4, 2024

tim.hodson Fri, 10/04/2024 - 10:51 Oct. 3, 2024 — GE HealthCare’s MIM Software has announced it received 510(k) clearance from the U.S. As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown.

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

Imaging Technology

JUNE 20, 2024

Additionally, the Omni platform is scalable, allowing radiology departments and healthcare facilities to upgrade the hardware and add service lines to help meet growing demand as well as optimize clinical capabilities, ensure access to the latest technology, and accommodate evolving community needs for many years to come.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104

AuntMinnie

NOVEMBER 4, 2024

reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclear medicine, and radiation oncology. increase in the conversion factor from 2024, rising to $89.16 Although the 2025 MPFS calls for an overall 2.9%

Radiation Oncology 80

Radiation Oncology Nuclear Medicine Medicare Radiation 80

Imaging Technology

NOVEMBER 1, 2024

tim.hodson Fri, 11/01/2024 - 12:58 Blue Earth Therapeutics Ltd, recently announced further positive developments for its novel investigational radioligand therapies. The Phase 2 clinical trial of Lutetium ( 177 Lu) rhPSMA-10.1 Journal of Nuclear Medicine (2024). Injection was completed in July. 1 Ells, Zachary, et al.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Clinic 52

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans earned his PhD in organic chemistry from the Scripps Research Institute.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

AuntMinnie

JANUARY 30, 2024

Efforts to bring quantitative MRI analysis into clinical practice received a boost with the availability of two new Category III Current Procedural Terminology (CPT) codes for brain MRI. Effective January 1, 2024, the new codes, 0865T and 0866T, support the use of software to analyze brain MRI exams with comparison to prior studies.

MRI 105

MRI Radiopharmaceuticals Disease Imaging 105

AuntMinnie

JANUARY 19, 2024

Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PET scans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime. This has led to inadequate payment for precision radiopharmaceuticals and challenges for some providers seeking to offer these imaging services.

Disease 52

Disease Medicare Imaging PET Scan 52

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JUNE 10, 2024

milla1cf Mon, 06/10/2024 - 18:25 June 10, 2024 — Jean-Luc C. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible. “As

Nuclear Medicine 45

Nuclear Medicine Radiopharmaceuticals Health Science Hospital 45

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 18, 2023

The joint venture remains subject to further closing conditions expected to be satisfied in early 2024. Targeted radiopharmaceuticals are created by linking a therapeutic radioisotope to a targeting molecule (e.g., a new joint venture company between CNL and ITM for the industrial scale production of Actinium-225 (225Ac).

Radiopharmaceuticals 115

Radiopharmaceuticals Pharmaceutical Radiation Medical 115

AuntMinnie

JUNE 9, 2024

As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible," Urbain said in an SNMMI announcement. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40